DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02627 AB&B BIO-TECH-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders An Youcai (34.65%)
Jiangsu Jiequan Gaotejia Medical Industry Investment Fund (Limited Partnership) (7.55%)
Shi Fanhui & Family (6.80%)
Wang Shuguang (5.51%)		 Sector Health Care & Biotechnology
Web Site http://www.abbbio.com Tel (86 523) 8220-5786
Email info@abbbio.com.cn Fax (86 523) 8220-5726
Related Equities N/A
Principal Activities The Group is principally engaged in the research and development, manufacturing and commercialization of vaccine products for human use.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top